Study of the Effects of L-tryptophane Nanoparticles on Motor Behavior in Alzheimer's Experimental Models

Author(s): Andressa Leticia Miri*, Andressa Panegalli Hosni, Jossinelma Camargo Gomes, Rubiana Mara Mainardes, Najeh Maissar Khalil, Rossana Gabriela del Jesus Vásquez Marcano, Mário César da Silva Pereira, Ivo Ilvan Kerppers.

Journal Name: CNS & Neurological Disorders - Drug Targets

Volume 18 , Issue 1 , 2019

Become EABM
Become Reviewer


Background: Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive and incapacitating decay of cognitive, neuropsychiatric, and behavioral manifestations. L-tryptophan is the precursor amino acid of serotonin, which is a neurotransmitter responsible for mood balance and the sense of well-being and can be administered in the form of nanoparticles. Objective: This study analyzed the effectiveness of L-tryptophan nanoparticles and L-tryptophan on behavioral physiological alterations resulting from AD in animal models.

Method: The sample consisted of 50 Rattus norvegicus rats, divided in 10 groups with 5 animals each: one negative control (NC), three positive control groups (C3, C7, and C21), three groups treated with L-tryptophan nanoparticles (T3N, T7N, and T21N) at the concentration of 1.5 mg, and three groups treated with L-tryptophan (T3L, T7L, and T21L) at the concentration of 1.5 mg. The rats underwent stereotactic surgery to induce AD through the injection of amyloid beta-amyloid peptide1-42 in the intracerebroventricular region. All rats were submitted to pre- and post-surgery and post-treatment motor behavior evaluation through the Later Water Maze (LWM) and elevated cross-labyrinth (ECL). Histological analysis was performed to verify the presence of senile plaques, and the statistical analysis used the unpaired T-test.

Results: Significant intergroup differences were observed in some of the evaluated parameters between treated and untreated groups.

Conclusion: It was concluded that the treatment with L-tryptophan nanoparticles was beneficial to improve behavioral reactions in the Alzheimer's model.

Keywords: Dementia, serotonin, neuroinflammation, neurodegeneration, neuroscience, nanoscience.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [44 - 51]
Pages: 8
DOI: 10.2174/1871527317666181105111157
Price: $95

Article Metrics

PDF: 6